Bridge Therapeutics®, based in Birmingham, Ala., is an innovative development-stage specialty pharmaceutical company pursuing U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) approvals of a patented (U.S. Patent #8410092) drug combination, BT-205, for the treatment of chro... Read more
Org chart
Collapse
Board & advisors
Teams
Offices
Bristol-Myers Squibb
320 followers
Astellas Pharma
63 followers
Viatris
54 followers
NYU Langone Health
51 followers
Alnylam Pharmaceuticals
50 followers
Syneos Health
38 followers
Prescient Healthcare Group
29 followers
Parexel
21 followers
West Pharmaceutical Services
12 followers
Curia Global
9 followers
Clario
6 followers
HistoSonics
6 followers